NASDAQ: SERA
Sera Prognostics, Inc.
Healthcare · Medical - Diagnostics & Research
After hours: $2.01(0%) · as of 7:34 PM ET
Market Cap
$76.76M
52w High
$3.95
52w Low
$1.56
P/E
-3.09
Volume
30.86K
Outstanding Shares
38.19M
Price vs Fundamentals
Why The Stock Is Moving
Note: The most recent financial data is over 3 months old. Metrics shown may not reflect the latest reporting period.
What changed
The stock fell 14.1% over the last year. Revenue declined 50.43% over the trailing twelve months. Operating margin moved from -31,989.57% to -64,235.09%. Free cash flow declined 1.65% over the trailing twelve months.
What the market seems to be pricing
The market appears to be responding to weaker operating momentum rather than only rerating the stock.
What would invalidate this read
Operating margin stands at -64,235.09%. Revenue declined 50.43% — this read reverses if that trend stabilizes. Free cash flow fell 1.65% — a return toward positive territory would undermine the deterioration thesis. If margins and cash flow stabilize while the stock stays depressed, the gap shifts from fundamental damage toward pure multiple compression.
Company profile
Sera Prognostics, Inc. is a women's health diagnostics firm that focuses on creating, advancing, and bringing to market biomarker tests aimed at improving pregnancy results.
Valuation
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Analyst consensus
4
Buy
1
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Aug 12, 2026
Q3 FY26 · EPS est -$0.14 · Revenue est $71.38K
View